An industry perspective approach and control strategy for implementation of ready-to-use cells in bioassays: survey outcome and recommendations

0Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The BioPhorum Development Group is an industry collaboration enabling the sharing of common practices for the development of biopharmaceuticals. Bioassays are an important part of an analytical control system. Utilization of ready-to-use cells can increase operational flexibility and improve efficiency by providing frozen cell banks uniform stock while removing challenges associated with maintaining cultured cells. The BioPhorum Development Group-Bioassay workstream conducted an intercompany benchmarking survey and group discussions around the use of ready-to-use cells for bioassays. The results of the collaboration provide alignment on nomenclature, production, qualification and implementation of ready-to-use cells to support the assay life cycle.

Cite

CITATION STYLE

APA

White, J. R., Ahmed, S., Amstrup, J., Bennington, P., Cheng, Z. J., Day, P., … Wang, J. (2024). An industry perspective approach and control strategy for implementation of ready-to-use cells in bioassays: survey outcome and recommendations. BioTechniques, 76(4), 135–144. https://doi.org/10.2144/btn-2023-0086

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free